Tissue microarray use for immunohistochemical study of ameloblastoma.

Area of Science:

• Oral pathology
• Oncology
• Molecular biology

Background:

• Ameloblastoma is an aggressive odontogenic tumor known for high recurrence rates.
• Understanding ameloblastoma's molecular mechanisms is crucial for improved treatment strategies.
• Tissue microarray (TMA) is a high-throughput technique with potential for ameloblastoma research, but requires validation.

Purpose of the Study:

• To validate the use of TMA for immunohistochemical analysis of ameloblastoma.
• To determine the optimal TMA design for ameloblastoma studies.

Main Methods:

• Forty ameloblastoma cases were used to create TMA blocks with 1.0-mm and 2.0-mm cores, assembled in triplicate.
• Immunohistochemistry was performed for cytokeratins 14 and 19, Bcl-2, and Ki-67.
• TMA results were compared with conventional whole-section slides (CWSS) using semiquantitative analysis.

Main Results:

• Both 1.0-mm and 2.0-mm cores showed significant correlation with CWSS, particularly for Ki-67 and CK19.
• No significant differences were observed between core sizes or between duplicate and triplicate arrangements.
• 1.0-mm TMA cores exhibited a higher rate of core loss (33.74%) compared to 2.0-mm cores (4.99%).

Conclusions:

• Manual arrayer-based 1.0-mm TMA in duplicate is a valid and effective method for ameloblastoma immunohistochemical studies.
• This method demonstrates satisfactory agreement between TMA cores and CWSS.
• TMA provides a reliable approach for investigating the molecular characteristics of ameloblastoma.